HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Yin Yan Selected Research

Albumins

4/2022Cardiotoxicity monitoring of pyrotinib in combination with nab-paclitaxel, doxorubicin, and cyclophosphamide in HER2-positive breast cancer: a single-armed clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Yin Yan Research Topics

Disease

1Cardiotoxicity
04/2022
1Breast Neoplasms (Breast Cancer)
04/2022
1Osteoarthritis
08/2014

Drug/Important Bio-Agent (IBA)

1liposomal doxorubicin (Doxil)FDA Link
04/2022
1human ERBB2 proteinIBA
04/2022
1130-nm albumin-bound paclitaxelIBA
04/2022
1AlbuminsIBA
04/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2022
1Paclitaxel (Taxol)FDA LinkGeneric
04/2022
1pyrotinibIBA
04/2022
1Estradiol (Delestrogen)FDA LinkGeneric
08/2014